Researchers also combined the 121 SNPs they found with pharmacy data to develop a risk score to predict when patients would start lipid-lowering treatments.
At the Precision Medicine World Conference this week, researchers discussed how they plan to return genomic results to participants of research-focused sequencing studies.
Genome Medical will use the proceeds of its Series A-1 financing to expand its nationwide footprint, as well as to invest in its telegenomics platform.
Based on genotyping data for tens of thousands of individuals across ancestry groups, investigators identified 47 new and known intraocular pressure-associated loci.
The consortium aims to advance the use of genomics in the clinic, with a particular focus on diverse and underserved patient populations.
A new study from researchers at UCSF and Kaiser Permanente has uncovered a set of genes that appear to regulate natural variations in prostate-specific antigen.
The healthcare provider plans to build a large biobank to conduct precision medicine research based on genomics, lifestyle, and environmental factors.
The Kaiser Permanente Northwest researchers focused on patient preferences, their ability to handle unexpected results, and the time required for genetic counseling.
The latest analysis of CYP2C19 genotyping to guide antiplatelet therapy tries to address cost questions from the vantage of a payor or large healthcare system.
The three papers published in Genetics will provide the basis for future investigations into the links between genetics, environment, and disease risk.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
The Associated Press reports that gene-edited food may soon be for sale.
The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.
In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.